Clinical Trial

A Study of VV-14305 for the Treatment of Thyroid Eye Disease

Name: A Study of VV-14305 for the Treatment of Thyroid Eye Disease — clinical trial record (NCT07404111)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RECLAIM

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The goal of this study is to evaluate the safety, tolerability, and efficacy of KRIYA-586 (VV-14305) in treating thyroid eye disease (TED).

Trial Details

NCT Number	NCT07404111
Lead Sponsor	Kriya Therapeutics, Inc.
Conditions	Thyroid Eye Disease (TED)
Enrollment	110 participants
Start Date	2026-02
Primary Completion	2028-02 (estimated)
Study Completion	2029-02 (estimated)
Updated on ClinicalTrials.gov	2026-02-11